Duh MS - Search Results

1

Dosing patterns and costs of erythropoietic agents in patients with chronic kidney disease not on dialysis in managed care organizations.

Duh MS, Mody SH, Scott McKenzie R, Lefebvre P, Gosselin A, Tak Piech C. Duh MS, et al. Clin Ther. 2006 Sep;28(9):1443-50. doi: 10.1016/j.clinthera.2006.09.020. Clin Ther. 2006. PMID: 17062316

2

Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve.

Duh MS, Lefebvre P, Fastenau J, Piech CT, Waltzman RJ. Duh MS, et al. Oncologist. 2005 Jun-Jul;10(6):438-48. doi: 10.1634/theoncologist.10-6-438. Oncologist. 2005. PMID: 15967837 Free article.

3

The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia.

Ben-Hamadi R, Duh MS, Aggarwal J, Henckler A, McKenzie RS, Tak Piech C. Ben-Hamadi R, et al. Among authors: duh ms. Curr Med Res Opin. 2005 Oct;21(10):1677-82. doi: 10.1185/030079905X65501. Curr Med Res Opin. 2005. PMID: 16238908

4

Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia.

Campos SM, Duh MS, Lefebvre P, Rosberg J. Campos SM, et al. Among authors: duh ms. J Natl Compr Canc Netw. 2005 Nov;3(6):807-16. doi: 10.6004/jnccn.2005.0049. J Natl Compr Canc Netw. 2005. PMID: 16316616

5

Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations.

Lefebvre P, Gosselin A, McKenzie RS, Mody SH, Piech CT, Duh MS. Lefebvre P, et al. Among authors: duh ms. Curr Med Res Opin. 2006 Sep;22(9):1623-31. doi: 10.1185/030079906X120968. Curr Med Res Opin. 2006. PMID: 16968565

6

Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease.

Lefebvre P, Duh MS, Buteau S, Bookhart B, Mody SH. Lefebvre P, et al. Among authors: duh ms. J Am Soc Nephrol. 2006 Dec;17(12):3497-502. doi: 10.1681/ASN.2006030289. Epub 2006 Nov 2. J Am Soc Nephrol. 2006. PMID: 17082245

7

Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations.

Duh MS, Mody SH, McKenzie RS, Lefebvre P, Gosselin A, Bookhart BK, Piech CT. Duh MS, et al. Drugs Aging. 2006;23(12):969-76. doi: 10.2165/00002512-200623120-00004. Drugs Aging. 2006. PMID: 17154661

8

The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease.

Lefebvre P, Duh MS, Mody SH, Bookhart B, Piech CT. Lefebvre P, et al. Among authors: duh ms. Dis Manag. 2007 Feb;10(1):37-45. doi: 10.1089/dis.2006.626. Dis Manag. 2007. PMID: 17309363

9

Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.

Andermann F, Duh MS, Gosselin A, Paradis PE. Andermann F, et al. Among authors: duh ms. Epilepsia. 2007 Mar;48(3):464-9. doi: 10.1111/j.1528-1167.2007.01007.x. Epilepsia. 2007. PMID: 17346246 Free article.

10

Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study.

Zilberberg MD, Carter C, Lefebvre P, Raut M, Vekeman F, Duh MS, Shorr AF. Zilberberg MD, et al. Among authors: duh ms. Crit Care. 2007;11(3):R63. doi: 10.1186/cc5934. Crit Care. 2007. PMID: 17553147 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters